Analysis of NRP2 transfected cell lines and NRP2 expressing xenografts established that NRP2-expressing tumor cells displayed an immunohistochemical phenotype of EMT characterized by the loss of E-Cadherin and an increase of vimentin expression (Figure 4). Here, CDH1 is linked to neoplasm.